This company seems to have been delisted
Reason: Acquired by Merck
Source: https://www.merck.com/news/merck-completes-acquisition-of-acceleron-pharma-inc/
Reason: Acquired by Merck
Source: https://www.merck.com/news/merck-completes-acquisition-of-acceleron-pharma-inc/
Acceleron Pharma
XLRN
$255.92
Share price
0.00%
Change (1 day)
15,915.82%
Change (1 year)
Categories
Earnings for Acceleron Pharma (XLRN)
Earnings in 2021 (TTM): -C$0.33 Billion
According to Acceleron Pharma's latest financial reports the company's current earnings are C$0.11 Billion. In 2020 the company made an earning of -C$0.24 Billion a decrease over its 2019 earnings that were of -C$0.2 Billion.
Earnings history for Acceleron Pharma from 2012 to 2021
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2021 (TTM) | -C$0.33 Billion | 34.72% |
| 2020 | -C$0.24 Billion | 22.62% |
| 2019 | -C$0.2 Billion | 9.67% |
| 2018 | -C$0.18 Billion | 13.12% |
| 2017 | -C$0.16 Billion | 92.99% |
| 2016 | -C$81.6 Million | -6.39% |
| 2015 | -C$87.17 Million | 20.95% |
| 2014 | -C$72.07 Million | 154.15% |
| 2013 | -C$28.36 Million | -36.22% |
| 2012 | -C$44.46 Million |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 | C$6.59 B | -1,903.99% | 🇺🇸 USA |
 | C$6.84 B | -1,970.88% | 🇺🇸 USA |
 | C$24.97 B | -6,926.91% | 🇺🇸 USA |
 | -C$26 Million | -92.89% | 🇺🇸 USA |
 | -C$0.2 Billion | -47.47% | 🇺🇸 USA |
 | -C$0.44 Billion | 17.66% | 🇺🇸 USA |
 | C$15.91 B | -4,449.70% | 🇺🇸 USA |